Publication | Open Access

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects

Metastatic Breast CancerAntitumor ActivityBiological EffectsBreast OncologyMedicineMetronomic TherapyPharmacologyBreast CancerPharmacotherapyAnti-cancer AgentMetronomic ChemotherapyCancer TreatmentOncologyCancer ChemotherapyCancer Research